MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19

    NEXT STORY
    BeiGene Announces Appointment of Angus Grant as Chief Business Executive
    PREV STORY
    Global Therapeutic Vaccines Market By Type, By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Basilea announces change in the Management Committee – Adesh Kaul appointed CFO

    Basel, February 7, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the ...

    author_avatar
    NASDAQ Market News

    RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018

    TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ...

    author_avatar
    NASDAQ Market News

    Global Microbiomes Market Insights & Forecast Report 2020: Market is Forecast to Reach US$9,376 Million in 2024, Growing at a CAGR of 135.47% During 2018-2024

    author_avatar
    NASDAQ Market News